Suspended

ANOSTOOLStudy of the Microbiological Profile of Stool in Patients With Anorexia Nervosa

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
DNA Samples
Who is being recruted

Anorexia Nervosa+3

+ Feeding and Eating Disorders

+ Mental Disorders

From 18 to 30 Years
See all eligibility criteria
How is the trial designed

Other

Utilizing specific methods not covered by standard models in order to address unique research questions.
Observational
Study Start: May 2019
See protocol details

Summary

Principal SponsorCentre Hospitalier Universitaire de Saint Etienne
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: May 15, 2019

Actual date on which the first participant was enrolled.

Anorexia nervosa is an eating disorder whose symptomatology induces a modification of the intestinal microbiota. To date, studies have shown variable profiles without linking them to metabolic and neuropsychological energy phenotyping. This intestinal dysbiosis could be involved in the maintenance of the disorders. Bidirectional communication channels exist between the microbiota, the intestine and the brain. Anomalies in these pathways could explain the impact of the microbiota on the pathophysiology of anorexia nervosa. Therapeutic interventions would then be possible to restore the microbiota in anorexia nervosa and influence the treatment of this disease. This study aims to explore the hypothesis of disruption of the microbiota-intestinal-brain axis transversely and measuring the intestinal microbiota, urinary metabolome, biological factors nutritional, immunological and physiological plasma plasma of the intestine, and finally, the psychological dimensions characteristic of anorexia nervosa.

Official TitleStudy of the Microbiological Profile of Stool in Patients With Anorexia Nervosa
NCT03736642
Principal SponsorCentre Hospitalier Universitaire de Saint Etienne
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Other

Some studies use unique or mixed approaches that don't fit standard categories. These may include innovative observational methods or studies tailored to specific research questions.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Female

Biological sex of participants that are eligible to enroll.

From 18 to 30 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Anorexia NervosaFeeding and Eating DisordersMental DisordersSigns and SymptomsSigns and Symptoms, DigestivePathological Conditions, Signs and Symptoms

Criteria

Inclusion criteria common to all four groups * Patient affiliated or entitled to a social security scheme * Patient who received informed information about the study * Patient does not object to participating in the study Inclusion criteria specific to mental anorexia * BMI between 13 and 17.5 kg/m2 * Diagnostic and Statistical Manual of Mental Disorders IV restrictive anorexia nervosa diagnostic criteria * Evolution of the troubles since less than 1 year. * with feeling of hunger: "hunger" = total score on the 24-hour hunger scale \> 15 and presence of the three prandial peaks (score = 3) * having lost the feeling of hunger: "not hungry" = total score on the 24-hour hunger scale ≤ 5 and absence of the three prandial peaks (score ≤ 2) Inclusion criteria specific to constitutionally thin patients * BMI between 13 and 17.5 kg/m2 * Stable weight for at least 3 months * No eating disorder * No markers of undernutrition Inclusion criteria specific to normal weight subjects * 20 kg/m2 ≤ BMI ≤ 25 kg/m2 * Stable weight for at least 3 months * No eating disorder * No markers of undernutrition Non-inclusion criteria for all subjects : * Antibiotic treatment during the 2 months preceding the sampling. * History of immune system/autoimmune disease: Immune deficiency, Crohn's disease, systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, psoriasis, Behçet's disease, celiac disease, type I diabetes. * History of metabolic pathology: intestinal malabsorptive disease * Medical or surgical history deemed by the investigator to be incompatible with this study. * Severe progressive condition other * Pregnant woman * Majors under guardianship or subjects deprived of their liberty by judicial or administrative decision * Ongoing psychotropic treatment * Progressive diarrhea (Bristol Type V and VI)

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Chu Saint-Etienne

Saint-Etienne, FranceOpen Chu Saint-Etienne in Google Maps
SuspendedOne Study Center